Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: A phase III trial

被引：0

作者：

Oyen, W

Massuger, L

Verheijen, R

Seiden, M

Benigno, B

Lopes, A

Soper, J

Markowska, J

Vyzula, R

Lambert, H

Epenetos, A

机构：

[1] Univ Nijmegen, Med Ctr, NL-1081 HV Nijmegen, Netherlands

[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, 02114, Netherlands

[3] Massachusetts Gen Hosp, Boston, MA USA

[4] Ovarian Canc Inst, Atlanta, GA USA

[5] Queen Elizabeth Hosp, Gateshead, England

[6] Duke Univ, Med Ctr, PL-60965 Durham, NC USA

[7] Poznan Univ Tech, Sch Med, Poznan, Poland

[8] Masaryk Univ, Ctr Oncol, Brno, Czech Republic

[9] Hammersmith Hosp, London, England

[10] St Bartholomews Hosp, London, England

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：528 / 528

页数：1